Drugs / AVX70481
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06998004 | Jun 2024 → Jan 2026 | rabies, yellow fever | AstriVax Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AVX70481 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06998004 ↗ |
| Modality | Vaccine | “investigational vaccine” NCT06998004 ↗ |